TASCINI, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 4.785
EU - Europa 1.755
AS - Asia 802
AF - Africa 20
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 7.376
Nazione #
US - Stati Uniti d'America 4.765
IT - Italia 834
SG - Singapore 440
IE - Irlanda 283
CN - Cina 179
RU - Federazione Russa 170
UA - Ucraina 113
SE - Svezia 84
VN - Vietnam 78
DE - Germania 75
FI - Finlandia 47
TR - Turchia 38
IN - India 37
FR - Francia 35
GB - Regno Unito 26
BE - Belgio 21
TG - Togo 19
AT - Austria 15
CA - Canada 11
HK - Hong Kong 9
MX - Messico 8
NL - Olanda 8
TW - Taiwan 8
PL - Polonia 7
ES - Italia 6
BR - Brasile 5
CH - Svizzera 4
DK - Danimarca 4
CZ - Repubblica Ceca 3
EU - Europa 3
GR - Grecia 3
HU - Ungheria 3
JP - Giappone 3
PE - Perù 3
RS - Serbia 3
KG - Kirghizistan 2
KR - Corea 2
LT - Lituania 2
LV - Lettonia 2
PH - Filippine 2
RO - Romania 2
SI - Slovenia 2
AU - Australia 1
BO - Bolivia 1
CO - Colombia 1
ID - Indonesia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 7.376
Città #
Chandler 464
Redmond 384
Boardman 360
Singapore 336
Ashburn 320
Fairfield 307
Woodbridge 281
Dublin 267
Wilmington 251
Princeton 245
Houston 204
Ann Arbor 180
Udine 153
Seattle 131
Cambridge 129
Dong Ket 76
Dearborn 52
Milan 52
Jacksonville 51
Norwalk 44
Beijing 41
Izmir 37
Rome 37
Ogden 34
San Diego 32
Lappeenranta 25
Brussels 19
Guangzhou 19
Lomé 19
Los Angeles 19
Munich 19
Naples 18
Washington 17
Hyderabad 16
Des Moines 15
Bologna 13
Parma 13
Trieste 13
New York 12
Shanghai 11
Vienna 10
Florence 9
Pisa 9
Turin 9
Venice 9
Vicenza 9
London 8
Santa Clara 8
Dallas 7
Falls Church 7
Frankfurt am Main 7
Helsinki 7
Kunming 7
Montepulciano 7
Padova 7
Trento 7
Codroipo 6
Genoa 6
Lissone 6
Nanjing 5
Tirano 5
Venezia 5
Amsterdam 4
Andover 4
Bari 4
Copenhagen 4
Livorno 4
Maierato 4
Menlo Park 4
Molfetta 4
Ottawa 4
San Giorgio di Nogaro 4
Toronto 4
Valencia 4
Zhongli District 4
Acerra 3
Belgrade 3
Bolzano 3
Budapest 3
Busto Arsizio 3
Castelvetrano 3
Changsha 3
Chengdu 3
Chicago 3
Cinisello Balsamo 3
Council Bluffs 3
Gurugram 3
Jinan 3
Leawood 3
Majano 3
Moscow 3
New Delhi 3
Nola 3
Palmanova 3
Pieve a Nievole 3
Rimini 3
Romans d'Isonzo 3
San Salvo 3
Sassari 3
The Dalles 3
Totale 5.003
Nome #
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 212
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 141
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 137
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 136
Gestione Diagnostico-Terapeutica del Paziente di Area Critica con Infezione Grave da Patogeni Batterici Multiresistenti 134
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 130
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 124
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 119
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 114
Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards 112
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis 111
An Italian consensus for invasive candidiasis management (ITALIC) 109
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 107
The role of biofilm forming on mortality in patients with candidemia: a study derived from real world data 103
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 101
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 96
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 94
MR-proADM as prognostic factor of outcome in COVID-19 patients 93
Ceftobiprole: drug evaluation and place in therapy 91
Hyposmia and Dysgeusia in COVID-19: Indication to Swab Test and Clue of CNS Involvement 82
Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization 81
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 80
KPC-producing Klebsiella pneumoniae gut decolonisation following ceftazidime/avibactam-based combination therapy: A retrospective observational study 79
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination 76
Lung Ultrasound Signs and Their Correlation With Clinical Symptoms in COVID-19 Pregnant Women: The “PINK-CO” Observational Study 67
Use of colistin in adult patients: A cross-sectional study 63
Ampicillin and Ceftobiprole Combination for the Treatment of Enterococcus faecalis Invasive Infections: “The Times They Are A-Changin” 60
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors 56
Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19 54
Reading and understanding an antibiogram 53
Covid-19 and the role of smoking: the protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly). 52
The Fall in Antibody Response to SARS-CoV-2: A Longitudinal Study of Asymptomatic to Critically Ill Patients up to 10 Months after Recovery 49
Screening procedure for SARS-CoV-2 infection combining triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation recipients undergoing outpatient posttransplant follow-up 49
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 48
Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature 46
Liposome composition of colistin for intravenous, oral, and cutaneous therapheutic use, and process for its preparation 46
L'uso dei Farmaci Antifungini nel Paziente Critico. Le Infezioni Fungine nel Paziente Critico dal Laboratorio alla Clinica per Ottimizzare la Diagnosi e la Terapia 45
D-Dimer as Biomarker for Early Prediction of Clinical Outcomes in Patients With Severe Invasive Infections Due to Streptococcus Pneumoniae and Neisseria Meningitidis 45
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients 45
Risk factors and outcome of c. Difficile infection after hematopoietic stem cell transplantation 43
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality 43
Echocardiographic Comparison of COVID-19 Patients with or without Prior Biochemical Evidence of Cardiac Injury after Recovery 43
Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave 43
L'uso dei farmaci antimicrobici in terapia intensiva - Letteratura ragionata dell'antibiogramma 42
A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation 42
Population pharmacokinetics and pharmacodynamic target attainment of isavuconazole against aspergillus fumigatus and aspergillus flavus in adult patients with invasive fungal diseases: Should therapeutic drug monitoring for isavuconazole be considered as mandatory as for the other mold-active azoles? 42
Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia Giulia 42
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery 42
Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature 41
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients 40
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge 40
Added Value of Tc-99m-HMPAO Labeled Leukocyte SPECT/CT in the Characterization and Management of Patients with Infectious Endocarditis 40
A Randomized Controlled Trial to Examine the Efficacy and Safety of a New Super-Oxidized Solution for the Management of Wide Postsurgical Lesions of the Diabetic Foot 40
A Novel Immunosuppressive Strategy Combined with Preemptive Antiviral Therapy Improves the Eighteen-Month Mortality in HCV Recipients Transplanted with Aged Livers 40
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome 39
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience 39
2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS 39
A dangerous job 39
Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with covid-19 pneumonia: A prospective study 38
A cluster of COVID-19 cases in a small Italian town: a successful example of contact tracing and swab collection 37
Accuracy of point-of-care ultrasound to identify the source of infection in septic patients: a prospective study-comment 37
Extracellular vesicle features are associated with COVID-19 severity 36
Acid-suppressant therapy does not influence absorption of azoles used in candidemia 36
Antibiotic stewardship: a milestone in everyday clinical practice 36
A NEW IMMUNOSUPPRESSIVE STRATEGY COMBINED WITH EARLY ANTIVIRAL THERAPY IMPROVES SURVIVAL AND LEADS TO HCV ERADICATION AT THE SAME COST OF THE HBV PROPHYLAXIS 3 YEARS AFTER LIVER TRANSPLANTATION 36
Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients 36
A Rapid High-Performance Liquid Chromatography Method to Measure Linezolid and Daptomycin Concentrations in Human Plasma 35
Authors’ Reply to Cattaneo et al.: “Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6” 35
Icatibant in severe acute respiratory syndrome coronavirus 2 infection: A case report 35
Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection 35
Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department 34
One Word to Describe My Experience as a COVID-19 Survivor Six Months after Its Onset: Findings of a Qualitative Study 34
Approccio multidisciplinare alle infezioni intra-addominali. 33
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis 32
Using Metaphors to Understand Suffering in COVID-19 Survivors: A Two Time-Point Observational Follow-Up Study 31
L'uso dei farmaci antimicrobici in terapia intensiva - dal laboratorio alla clinica 31
Applying DNA barcoding for clinical diagnosis 31
AmpC -lactamase-producing Enterobacterales: what a clinician should know 31
A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway 31
Approach to patients with COVID-19 disease: The procedure in Udine 31
Enterobacterales multiresistenti - Dal laboratorio alla clinica 30
La gestione delle resistenze antimicrobiche 30
Resistant Infections in the Diabetic Foot: A Frightening Scenario 30
Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6 29
INFEZIONI da GRAM POSITIVI per QUADRO SINDROMICO Dal laboratorio alla clinica 28
A Position Paper on IgM-Enriched Intravenous Immunoglobulin Adjunctive Therapy in Severe Acute Bacterial Infections: The TO-PIRO SCORE Proposal 28
A proposal for distinguishing between bacterial and viral meningitis using genetic programming and decision trees 28
Response to a massive SARS-CoV-2 infection in a nursing home transformed into a caring center 27
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply 27
La gestione clinico-microbiologica del paziente con infezioni batteriche gravi. Un approccio terapeutico guidato 27
A prediction rule for early recognition of patients with candidemia in Internal Medicine: results from an Italian, multicentric, case-control study 27
Longest incubation period of Mycobacterium chimaera infection after cardiac surgery 27
Klebsiella pneumoniae producing kpc-type carbapenemase: From bench to bedside 27
Prévalence du COVID-19 chez les patients atteints de rhumatismes inflammatoires chroniques traités par biothérapies ou inhibiteurs des JAK : une étude basée sur la population au cours des deux premiers mois de l’épidémie de COVID-19 en Italie 27
‘Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients': author's response 26
Cefditoren: a clinical overview 26
L’interpretazione del fenotipo antibiotico come strumento per il clinico. 26
Acute varicella-zoster virus necrotizing meningoencephalomyelitis with sudden visual loss and paraparesis in an HIV-infected patient 26
Breakthrough pneumonia, meningitis and bloodstream infection due to Streptococcus pneumoniae during cefixime therapy 26
{CORonavirus}-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure ({CORMOR}) multicentric prospective randomized clinical trial 26
Totale 5.518
Categoria #
all - tutte 65.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.675


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020483 0 0 0 0 0 113 135 75 66 38 20 36
2020/20212.003 26 50 22 45 20 72 60 411 959 99 124 115
2021/20221.478 78 78 74 50 85 31 52 105 95 222 331 277
2022/20231.506 271 124 21 141 121 410 47 70 168 15 65 53
2023/2024922 102 46 60 52 98 108 41 147 59 83 37 89
2024/20251.337 143 364 215 250 136 229 0 0 0 0 0 0
Totale 8.576